Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05389462
Status:
RECRUITING
Last Update Posted:
2024-04-18
First Post:
2022-05-20
Brief Title:
A Study of Mipasetamab Uzoptirine ADCT-601 in Participants With Solid Tumors
Sponsor:
ADC Therapeutics SA
Organization:
ADC Therapeutics SA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-20
First Submit QC Date:
May 20 2022
Study First Post Date:
2022-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-13
Last Update Post Date:
2024-04-18
Last Update Post Date Type:
ACTUAL